A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

PHASE2CompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

January 12, 2017

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
UC (Urothelial Cancer)
Interventions
DRUG

pemigatinib

Pemigatinib once a day by mouth for 2 consecutive weeks and 1 week off therapy.

DRUG

pemigatinib

Pemigatinib once a day by mouth continuously.

Trial Locations (96)

2100

Rigshospitalet, Copenhagen

2650

UZ Antwerpen, Edegem

8500

AZ Groeninge Campus Loofstraat, Kortrijk

8800

AZ Delta, Roeselare

9000

AZ Sint-Lucas - Campus Sint-Lucas, Ghent

11042

Northwell Cancer Institute, New Hyde Park

12200

Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin

12208

New York Oncology Hematology, P.C., Albany

14642

University of Rochester, Rochester

15240

VA Pittsburgh Healthcare System, Pittsburgh

17007

ICO Girona - Hospital Universitari de Girona Dr. Josep Trueta, Girona

18015

St. Luke's Hospital, Bethlehem

20133

Fondazione Del Piemonte Per L'Oncologia IRCC Candiolo, Candiolo

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

20246

Universitaetsklinikum Hamburg-Eppendorf, Hamburg

21201

University of Maryland, Greenebaum Cancer Center, Baltimore

23502

Virginia Oncology Associates - Hampton, Norfolk

25030

CHU Besançon - Hôpital Jean Minjoz, Besançon

27514

University of North Carolina at Chapel Hill, Chapel Hill

28050

Centro Integral Oncologico Clara Campal, Madrid

29572

Carolina Urologic Research Center, Myrtle Beach

30322

Emory University School of Medicine, Atlanta

31008

Clinica Universidad de Navarra, Pamplona

31059

Institut Claudius Regaud-Oncopole, Toulouse

32804

Florida Hospital Cancer Institute, Orlando

33075

Groupe Hospitalier Saint André - Hôpital Saint André, Bordeaux

33140

Mount Sinai Medical Center, Miami Beach

37232

Vanderbilt University Medical Center, Nashville

40138

Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna

44805

ICO - Site René Gauducheau, Saint-Herblain

45242

Oncology Hematology Care, Inc., Cincinnati

47923

Ospedale degli Infermi, Rimini

48149

Universitaetsklinikum Muenster, Münster

49933

ICO - Site Paul Papin, Angers

50937

Universitaetsklinikum Koeln, Cologne

52656

Chaim Sheba Medical Center, Ramat Gan

53100

A.O.U. Senese Policlinico Santa Maria alle Scotte, Siena

San Camillo-Forlanini Hospital, Siena

53226

Medical College of Wisconsin, Milwaukee

53792

University of Wisconsic Hospital and Clinic, Madison

55125

Minnesota Oncology Hematology, P.A., Woodbury

55131

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz

64239

Tel Aviv Sourasky Medical Center, Tel Aviv

67091

CHU Strasbourg - Nouvel Hôpital Civil, Strasbourg

68130

GU Research Network, Omaha

69373

Centre Leon Berard, Lyon

70300

Assaf Harofeh Medical Center, Be’er Ya‘aqov

71013

IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo

72076

Universitaetsklinikum Tuebingen, Tübingen

72622

Studienpraxis Urologie Drs. Feyerabend, Nürtingen

75010

Hopital Saint Louis, Paris

75090

Texas Oncology, P.A. - Sherman, Sherman

75246

Texas Oncology - Baylor Charles A. Sammons, Dallas

75571

Groupe Hospitalier Pitie-Salpetriere, Paris

76508

Baylor Scott & White Health, Temple

77024

Texas Oncology, Houston

78731

Texas Oncology, P.A. - Austin, Austin

80131

Azienda Ospedaliera Di Rilievo Nazionale A. Cardarellio, Napoli

80303

Rocky Mountain Cancer Centers, Boulder

81601

Calaway-Young Cancer Center at Valley View Hospital, Glenwood Springs

84112

Huntsman Cancer Institute, Salt Lake City

85711

Arizona Oncology Associates (Wilmot), Tucson

92123

Sharp Memorial Hospital, San Diego

94158

UCSF Helen Diller Family Comprehensive Care Center, San Francisco

94805

Institut Gustave Roussy, Villejuif

97062

Compass Oncology the Northwest Cancer Specialists, Tualatin

97229

Oregon Health & Science University, Portland

98405

Northwest Medical Specialties, PLLC, Tacoma

4428126

Meir Medical Center, Kfar Saba

8128582

Kyushu University Hospital, Fukuoka

8410101

Soroka University Medical Center, Beersheba

01805

Lahey Clinic Inc. - PARENT ACCOUNT, Burlington

89169-3321

TRIO - Comprehensive Cancer Centers of Nevada, Las Vegas

01067

Klinikum Dresden Standort Dresden-Friedrichstadt, Dresden

01307

Universitaetsklinikum Carl Gustav Carus TU Dresden, Dresden

00128

University Campus Bio-Medico di Roma, Rome

350-1298

Saitama Medical University International Medical Center, Hidaka-shi

036-8563

Hirosaki University Hospital, Hirosaki-shi

173-8606

Teikyo University Hospital, Itabashi-ku

173-8610

Nihon University Itabashi Hospital, Itabashi-ku

634-8522

Nara Medical University Hospital, Kashihara-shi

541-8567

Osaka International Cancer Institute, Osaka

362-0806

Saitama Cancer Center, Saitama

565-0871

Osaka University Hospital, Suita-shi

329-0498

Jichi Medical University Hospital, Tochigi

1081 HV

VU Medisch Centrum, Amsterdam

4535 PA

Zorgsaam Ziekenhuis, Terneuzen

Unknown

HagaZiekenhuis Van Den Haag, The Hague

5912 BL

Viecuri Medisch Centrum, Venlo

08035

Hospital Universitari Vall d'Hebron, Barcelona

NW1 2PG

University College London Hospitals, London

SE1 9RT

Guy's Hospital, London

W6 8RF

Charing Cross Hospital, London

NG5 1PB

Nottingham University Hospitals City Campus, Nottingham

G12 OYN

Beatson West of Scotland Cancer Centre, Glasgow

B15 2TH

Queen Elizabeth Hospital, Birmingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Incyte Corporation

INDUSTRY